Back to 
Ensign Peak Advisors, Inc
Ensign Peak Advisors, Inc
CUE
Showing 0 of 4 quarters
Position history for Ensign Peak Advisors, Inc's holdings in CUE BIOPHARMA INC
No. Ensign Peak Advisors exited its CUE (Cue Biopharma) position in Q3 2022. Its Q2 2022 13F listed 17,960 shares worth $45,000. Ensign Peak Advisors first reported CUE in Q4 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.